Search Results 281-290 of 18464 for prednisone

1. GRAVITAS-301: A Study Of Itacitinib Or Placebo In Combination With Corticosteroids For Treatment Of Acute Graft-Versus-Host Disease - Mayo Clinic

   Any corticosteroid therapy for indications other than GVHD at doses > 1 mg/kg per day methylprednisolone (or prednisone equivalent) within 7 days of ...

2. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

   ... prednisone therapy at ≥ 1 mg/kg/day, a trial of calcineurin inhibitor for=> 3 months or a contraindication/intolerance to such therapy (diabetes ...

3. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   of prednisone or its equivalent. - Vaccinated with live, attenuated vaccines within 28 days of the first dose of the study drug - Active or prior documented ...

4. Sharing Mayo Clinic: Brothers bond over kidney disease and transplant

   He saw his local nephrologist every six weeks and was given heavy doses of prednisone. But over time, the disease progressed, and Scott was close to kidney ...

5. A Study To Evaluate The Effectiveness, Safety And Tolerability Of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis - Mayo Clinic

   Investigator site staff or members of their family. · Acute and Chronic present medical conditions. · Intake of greater than 15 mg of prednisone or equivalent per ...

6. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

   ... 1 of Cycle 1; Current use of systemic corticosteroids greater than (>) 20 mg prednisone per day (or equivalent), or prior anti-cancer therapy to include ...

7. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

   Steroids (i.e., prednisone/budesonide/budesonide MMX); Immunosuppressant (i.e., methotrexate/azathioprine/6-mercaptopurine); Other immunosuppressant (i.e. ...

8. A Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) - Mayo Clinic

   Participation eligibility · The patient has FSGS which in the Investigator's opinion is secondary to another condition · The patient has been taking prednisone at ...

9. Belimumab In Remission Of VASculitis - Clinical Trials

   Remission is defined as a Birmingham Vasculitis Activity (BVAS) score of 0 and receiving less than 10 mg/day of oral prednisone (or equivalent) on 2 consecutive ...

10. Ceftolozane/Tazobactam In Pediatric Patients With Nosocomial Pneumonia - Mayo Clinic

    ... prednisone for participants ≤ 20 kg, or > 40 mg of prednisone per day for participants > 20 kg, administered continuously for more than 14 days in the 30 ...